Search - tctmd.com

Displaying 501 - 520 of 1995

Sort: Relevancy | Date

Presentation TCT 2022

Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve

Presenter: Vinayak N. Bapat

September 18, 2022

Presentation TCT 2022

TCT 671: A Rare Complication During TAVI. Valve (and STENT) for Life.

Presenter: Christan Roguelov

September 18, 2022

The Dedicated JenaValve TAVR System for AI: Early EU and US Experiences

Presentation TCT 2022

The Dedicated JenaValve TAVR System for AI: Early EU Experience

Presenter: Alexander Tamm

September 18, 2022

Presentation TCT 2022

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

Presenter: Bruno Scheller

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

TCT 339: Less invasive Ventricular Enhancement (LIVE) procedure for the treatment of ischaemic heart disease - short and medium term outcomes

Presenter: Azfar Zaman

September 18, 2022

Presentation TCT 2022

For Most Patients, Only Spontaneous MI Is Relevant

Presenter: Alexandra J. Lansky

September 18, 2022

Presentation TCT 2022

Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study

Presenter: Firas Zahr

September 18, 2022

Presentation TCT 2022

Tips and Tricks with Workhorse TAVR Devices

Presenter: Raj Makkar

September 18, 2022

Presentation TCT 2022

Periprocedural MI Matters to All Patients!

Presenter: Milan Milojevic

September 18, 2022

Presentation TCT 2022

TCT 803: Aortic Stenosis with Left Main disease and Porcelain Aorta – Thrill of Victory

Presenter: Rahul Gupta

September 18, 2022

Presentation TCT 2022

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

Presenter: Hui Ying Ang

September 18, 2022

Presentation TCT 2022

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Presenter: Arpanjeet Kaur

September 18, 2022

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results

Presenter: Chet Rihal

September 18, 2022

Presentation TCT 2022

TCT 664: Emerging technique for coronary protection in Valve in Valve TAVR : The Shortcut Device

Presenter: Benjamin Séguy

September 18, 2022

Presentation TCT 2022

Case 3: Post-Partum May-Thurner Acute DVT

Presenter: Maya Serhal

September 18, 2022

Presentation TCT 2022

Trans-Apical Saturn TMVR System: 1-Year FIH Results (InnovHeart)

Presenter: Paolo Denti

September 18, 2022

Presentation TCT 2022

A Clinical Cardiologist’s View on How to Choose Revascularization Strategies

Presenter: Patrick O'Gara

September 18, 2022

Presentation TCT 2022

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

Presenter: John Shulze

September 18, 2022

Advertisement

Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve

TCT 671: A Rare Complication During TAVI. Valve (and STENT) for Life.

The Dedicated JenaValve TAVR System for AI: Early EU Experience

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

TCT 339: Less invasive Ventricular Enhancement (LIVE) procedure for the treatment of ischaemic heart disease - short and medium term outcomes

For Most Patients, Only Spontaneous MI Is Relevant

Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study

Tips and Tricks with Workhorse TAVR Devices

Periprocedural MI Matters to All Patients!

TCT 803: Aortic Stenosis with Left Main disease and Porcelain Aorta – Thrill of Victory

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results

TCT 664: Emerging technique for coronary protection in Valve in Valve TAVR : The Shortcut Device

Case 3: Post-Partum May-Thurner Acute DVT

Trans-Apical Saturn TMVR System: 1-Year FIH Results (InnovHeart)

A Clinical Cardiologist’s View on How to Choose Revascularization Strategies

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content